However, due to their significant increases in the tumor upon Flt3L treatment, the shift towards Tregs could be mediated via the increase in CD81+migcDC1s and migDCs as has previously been shown in the context of autoimmunity (33, 34). The gene discussed is FLT3LG; the disease is Autoimmunity.